Far Infrared Therapy on Peritoneal Function of CAPD Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT04344067

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04344067
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04344067. Randomized; no masking; primary purpose treatment. Start 2016-01-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Far Infrared Therapy on Peritoneal Function of CAPD Patients
Acronym
CAPD
Condition
End-stage Renal Disease
Intervention (Device)
Far Infrared Therapy
Lead sponsor
Taipei Veterans General Hospital, Taiwan (class: other government)

Record details

Record id
cardio:ct-nct04344067
Content hash
7a7a32fa2b806dbf716211f331a48e6c2fa8db4014222c7c471f2538c1b9b263